Thought Leadership | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Standard Essential Patents

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Blog | May 13, 2015

Reissue Was Broadening Where New Dependent Claims Exceeded Previously-Judged Scope of Independent Claim

Blog | May 12, 2015

ITC Economic Prong Requires Quantitative Analysis of Complainant's Domestic Activities

Blog | May 11, 2015

New Fee Proposals for the EU Unitary Patent and Unified Patent Court

Blog | May 06, 2015

DDE addresses various Daubert issues including EMVR and apportionment

Blog | May 05, 2015

Spain Fails to Block the EU Unitary Patent System

Blog | April 29, 2015

Baxter Files First Pharmaceutical ITC Complaint of 2015 to Block Importation of Novo Nordisk's Hemophilia A Treatment

Blog | April 29, 2015

Federal Circuit To Hear TTAB Appeal En Banc Concerning Denial Of Registration For Mark "THE SLANTS" That Was Found To Be Disparaging

Blog | April 28, 2015

The PTO's Refusal To Terminate Reexamination Proceedings In Light Of District Court Settlement Is Not Immediately Reviewable In Court

Blog | April 28, 2015

Does the Bar on Registration of Disparaging Marks Violate the First Amendment?

Blog | April 21, 2015

PTAB Encourages Parties to Consider Alternative Dispute Resolution

Blog | April 21, 2015

Name of Cactus Genus Not Registrable for Products Derived from Different Cactuses

Blog | April 21, 2015

Brand Management in a Global Market